Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Published:2013-09-27 Issue:22 Volume:19 Page:6322-6328
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Cardnell Robert J.,Feng Ying,Diao Lixia,Fan You-Hong,Masrorpour Fatemah,Wang Jing,Shen Yuqiao,Mills Gordon B.,Minna John D.,Heymach John V.,Byers Lauren A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

2. Recent advances and future strategies in first-line treatment of ES-SCLC;European Journal of Cancer;2024-03

3. A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer;Nature Communications;2024-01-22

4. Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers;OncoTargets and Therapy;2023-07

5. A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer;Cancer Biology & Therapy;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP